Business

FDA move on e-cigarettes means new risks for Fidelity funds



Fidelity Investments’ bet on a privately held maker of e-cigarettes faces new risks after U.S. health regulators on Wednesday said they are considering a ban on flavored versions of the popular “vaping” products.



LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *